Updated:
jVen Capital
jVen is a privately held life sciences investment management company. It is a venture capital and growth equity investor focused on personalized medicine,...
Overview
jVen is a privately held life sciences investment management company. It is a venture capital and growth equity investor focused on personalized medicine, genetics, and medical devices. Established by Evan Jones, jVen Capital works closely with its portfolio companies to help develop their visions and build successful businesses.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Jackson
Corporate office
Jackson, WY, United States
Principals
Evan Jones
Sector focus
Frequently asked questions
Does jVen Capital participate in fund commitments or only direct deals?
Available information does not clarify whether jVen Capital invests directly in companies, commits to external venture funds, or operates a hybrid model. The firm's strategy description references direct venture investment from seed through growth, but no fund-of-funds activity, SPV structures, or co-investment programs are publicly disclosed.
What investment stages does jVen Capital typically target?
The firm targets early-stage venture, including seed and startup rounds, as well as expansion and late-stage growth investments. This spans the full venture lifecycle under a generalist mandate. Actual check-size ranges or stage concentration weightings are not publicly stated.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: